BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer Without Their Disease Worsening Compared To Rituxan

  December 5, 2016

   · 

  16 min read
• Drug Development

  Alexion Release: New Data From ALXN1210 Dose-Escalation Study Presented At American Society of Hematology Show Rapid And Sustained Reductions In LDH In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

  December 5, 2016

   · 

  14 min read
• Business

  Ferring Pharma Collaborates With Metabogen AB On Development Of Microbiome-Based Treatment For Intrahepatic Cholestasis Of Pregnancy (ICP)

  December 5, 2016

   · 

  3 min read
• Business

  Vizient, Inc. Joins Momentum To Measure And Improve Progress Toward Safer Chemicals In The Healthcare Industry

  December 5, 2016

   · 

  3 min read
• Business

  Mission Therapeutics Appoints Colin Goddard As Chairman

  December 5, 2016

   · 

  3 min read
• Pharm Country

  Elsevier, Inc. Launches First Assessment Of Cancer Research On Global Scale In Partnership With US National Cancer Moonshot Initiative

  December 5, 2016

   · 

  4 min read
• Drug Development

  Bellicum Announces GoCAR-T And GoTCR Preclinical Presentations At The American Society of Hematology 2016 Annual Meeting

  December 5, 2016

   · 

  5 min read
• Drug Development

  GlycoMimetics, Inc.’ GMI-1271 Continues To Yield High Remission Rates, Favorable Tolerability In Two Phase II Arms Of Ongoing Phase I/II Clinical Trial For AML

  December 5, 2016

   · 

  5 min read
• Drug Development

  Dynavax Presents Clinical Data From Lead Cancer Immunotherapy Candidate, SD-101, In Combination With Targeted Low-Dose Radiation, At American Society of Hematology Annual Meeting

  December 5, 2016

   · 

  2 min read
• Drug Development

  Syros Pharma Presents Data At American Society of Hematology Annual Meeting Further Supporting Clinical Potential Of Its First-In-Class Selective Rara Agonist For Genomically Defined Subsets Of AML And MDS Patients

  December 5, 2016

   · 

  8 min read